Jia Jie Biomedical Co., Ltd.

TPEX:4109 Stock Report

Market Cap: NT$2.4b

Jia Jie Biomedical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Wen-Fang Hsieh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

How Much Did Jia Jie Biomedical's(GTSM:4109) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 21
How Much Did Jia Jie Biomedical's(GTSM:4109) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO

Wen-Fang Hsieh

less than a year

Tenure

Wen-Fang Hsieh is Chief Executive Officer of Jia Jie Biomedical Co. Ltd. from January 16, 2024.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.